Evaluation of Sca-1 and c-Kit as selective markers for muscle remodelling by nonhemopoietic bone marrow cells

Stem Cells

Volumn 25, Issue 6, 2007, Pages 1364-1374

  Wong, Sharon H A ^a,b,c   Lowes, Kym N ^a,b,c,i   Bertoncello, Ivan ^c,d,e   Quigley, Anita F ^a,b,c,g,i   Simmons, Paul J ^d,f   Cook, Mark J ^c,g   Kornberg, Andrew J ^a,b,h   Kapsa, Robert M I ^a,b,c,g,i  

^a National Muscular Dystrophy Research Centre   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e MONASH UNIVERSITY   (Australia)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^g ST VINCENT S HOSPITAL   (Australia)

^h ROYAL CHILDREN'S HOSPITAL   (Australia)

ⁱ BIONIC EAR INSTITUTE   (Australia)

Author keywords

Bone marrow; c Kit; mdx; Mice; Muscle regeneration; Muscular dystrophy; Stem cell antigen 1; Stem cells

Indexed keywords

ATAXIN 1; CELL SURFACE MARKER; STEM CELL ANTIGEN 1; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL FRACTIONATION; CELL LINEAGE; CELL POPULATION; CELL SELECTION; CONTROLLED STUDY; HEART MUSCLE; MALE; MESENCHYME CELL; MOUSE; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN;

ANIMALS; ANTIGENS, LY; BIOLOGICAL MARKERS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL FRACTIONATION; FLOW CYTOMETRY; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MUSCLE DEVELOPMENT; MUSCLE FIBERS; MUSCLES; PROTO-ONCOGENE PROTEINS C-KIT; REGENERATION;

MUS;

EID: 34547099074     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0194     Document Type: Article

References (131)

1. Hoffman EP, Brown RH Jr., Kunkel LM. Dystrophin: The protein product of the Duchenne Muscular Dystrophy locus. Cell 1987;51:919-928.
2. Arahata K, Ishiura S, Ishiguro T et al. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne Muscular Dystrophy peptide. Nature 1988;333:861-863.
3. Morgan JE, Watt DJ, Sloper JC et al. Partial correction of an inherited biochemical defect of skeletal muscle by grafts of normal muscle precursor cells. J Neurol Sci 1988;86:137-147.
4. Karpati G, Pouliot Y, Zubrzycka-Gaarn E et al. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am J Pathol 1989;135:27-32.
5. Partridge TA, Morgan JE, Coulton GR et al. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989;337:176-179.
6. Blaveri K, Heslop L, Yu DS et al. Patterns of repair of dystrophic mouse muscle: Studies on isolated fibers. Dev Dyn 1999;216:244-256.
7. Mueller GM, O'Day T, Watchko JF et al. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice. Hum Gene Ther 2002;13:1081-1090.
8. Tremblay JP, Malouin F, Roy R et al. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 1993;2:99-112.
9. Huard J, Roy R, Guerette B et al. Human myoblast transplantation in immunodeficient and immunosuppressed mice: Evidence of rejection. Muscle Nerve 1994;17:224-234.
10. Kinoshita I, Vilquin JT, Guerette B et al. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 1994;17:1407-1415.
11. Kapsa R, Quigley A, Lynch GS et al. In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement. Hum Gene Ther 2001;12:629-642.
12. Lu QL, Morris GE, Wilton SD et al. Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion. J Cell Biol 2000;148:985-996.
13. Bertoni C, Rando TA. Dystrophin gene repair in mdx muscle precursor cells in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides. Hum Gene Ther 2002;13:707-718.
14. Floyd SS Jr., Clemens PR, Ontell MR et al. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles. Gene Ther 1998;5:19-30.
15. Bachrach E, Li S, Perez AL et al. Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells. Proc Natl Acad Sci U S A 2004;101:3581-3586.
16. Holzer N, Hogendoorn S, Zurcher L et al. Autologous transplantation of porcine myogenic precursor cells in skeletal muscle. Neuromuscul Disord 2005;15:237-244.
17. Heslop L, Morgan JE, Partridge TA. Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J Cell Sci 2000;113:2299-2308.
18. Jejurikar SS, Kuzon WM Jr. Satellite cell depletion in degenerative skeletal muscle. Apoptosis 2003;8:573-578.
19. Cossu G, Mavilio F. Myogenic stem cells for the therapy of primary myopathies: Wishful thinking or therapeutic perspective? J Clin Invest 2000;105:1669-1674.
20. Melone MA, Peluso G, Petillo O et al. Defective growth in vitro of Duchenne muscular dystrophy myoblasts: The molecular and biochemical basis. J Cell Biochem 1999;76:118-132.
21. Blau HM, Webster C, Pavlath GK. Defective myoblasts identified in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 1983;80:4856-4860.
22. Pereira RF, Halford KW, O'Hara MD et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A 1995;92:4857-4861.
23. Young RG, Butler DL, Weber W et al. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 1998;16:406-413.
24. Lagasse E, Connors H, Al Dhalimy M et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1229-1234.
25. Krause DS, Theise ND, Collector MI et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001;105:369-377.
26. Ferrari G, Cusella-De Angelis G, Coletta M et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279:1528-1530.
27. Agbulut O, Menot ML, Li Z et al. Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy. Cardiovasc Res 2003;58:451-459.
28. Poulsom R, Forbes SJ, Hodivala-Dilke K et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 2001;195:229-235.
29. Cogle CR, Yachnis AT, Laywell ED et al. Bone marrow transdifferentiation in brain after transplantation: A retrospective study. Lancet 2004;363:1432-1437.
30. Corti S, Locatelli F, Donadoni C et al. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 2004;127:2518-2532.
31. Gussoni E, Soneoka Y, Strickland CD et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999;401:390-394.
32. Bittner RE, Schofer C, Weipoltshammer K et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl) 1999;199:391-396.
33. Fukada S, Miyagoe-Suzuki Y, Tsukihara H et al. Muscle regeneration by reconstitution with bone marrow or fetal liver cells from green fluorescent protein-gene transgenic mice. J Cell Sci 2002;115:1285-1293.
34. Gussoni E, Bennett RR, Muskiewicz KR et al. Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest 2002;110:807-814.
35. Torrente Y, Belicchi M, Sampaolesi M et al. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 2004;114:182-195.
36. Dezawa M, Ishikawa H, Itokazu Y et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 2005;309:314-317.
37. Corti S, Strazzer S, Del Bo R et al. A subpopulation of murine bone marrow cells fully differentiates along the myogenic pathway and participates in muscle repair in the mdx dystrophic mouse. Exp Cell Res 2002;277:74-85.
38. Brazelton TR, Nystrom M, Blau HM. Significant differences among skeletal muscles in the incorporation of bone marrow-derived cells. Dev Biol 2003;262:64-74.
39. Bossolasco P, Corti S, Strazzer S et al. Skeletal muscle differentiation potential of human adult bone marrow cells. Exp Cell Res 2004;295:66-78.
40. Camargo FD, Green R, Capetenaki Y et al. Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med 2003;9:1520-1527.
41. Corbel SY, Lee A, Yi L et al. Contribution of hematopoietic stem cells to skeletal muscle. Nat Med 2003;9:1528-1532.
42. Doyonnas R, LaBarge MA, Sacco A et al. Hematopoietic contribution to skeletal muscle regeneration by myelomonocytic precursors. Proc Natl Acad Sci U S A 2004;101:13507-13512.
43. Tamaki T, Uchiyama Y, Okada Y et al. Functional recovery of damaged skeletal muscle through synchronized vasculogenesis, myogenesis, and neurogenesis by muscle-derived stem cells. Circulation 2005;112:2857-2866.
44. Miles C, Sanchez MJ, Sinclair A et al. Expression of the Ly-6E. 1 (Sca-1) transgene in adult hematopoietic stem cells and the developing mouse embryo. Development 1997;124:537-547.
45. Ma X, Robin C, Ottersbach K et al. The Ly-6A (Sca-1) GFP transgene is expressed in all adult mouse hematopoietic stem cells. STEM CELLS 2002;20:514-521.
46. Jankowski RJ, Haluszczak C, Trucco M et al. Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: Potential for rapid isolation of muscle-derived stem cells. Hum Gene Ther 2001;12:619-628.
47. Asakura A, Seale P, Girgis-Gabardo A et al. Myogenic specification of side population cells in skeletal muscle. J Cell Biol 2002;159:123-134.
48. Majka SM, Jackson KA, Kienstra KA et al. Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest 2003;111:71-79.
49. Torrente Y, Tremblay JP, Pisati F et al. Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol 2001;152:335-348.
50. Torrente Y, Camirand G, Pisati F et al. Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model. J Cell Biol 2003;162:511-520.
51. Driessen RL, Johnston HM, Nilsson SK. Membrane-bound stem cell factor is a key regulator in the initial lodgment of stem cells within the endosteal marrow region. Exp Hematol 2003;31:1284-1291.
52. Thomas ML. The leukocyte common antigen family. Annu Rev Immunol 1989;7:339-369.
53. Goodell MA, Brose K, Paradis G et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996;183:1797-1806.
54. Jiang Y, Vaessen B, Lenvik T et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 2002;30:896-904.
55. Howell JC, Lee WH, Morrison P et al. Pluripotent stem cells identified in multiple murine tissues. Ann N Y Acad Sci 2003;996:158-173.
56. Bradford GB, Williams B, Rossi R et al. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp Hematol 1997;25:445-453.
57. Bertoncello I, Hodgson GS, Bradley TR. Multiparameter analysis of transplantable hemopoietic stem cells: I. The separation and enrichment of stem cells homing to marrow and spleen on the basis of rhodamine-123 fluorescence. Exp Hematol 1985;13:999-1006.
58. Takemitsu M, Arahata K, Nonaka I. Muscle regeneration in mdx mouse, and a trial of normal myoblast transfer into regenerating dystrophic muscle. Rinsho Shinkeigaku 1990;30:1066-1072.
59. Itagaki Y, Saida K, Iwamura K. Regenerative capacity of mdx mouse muscles after repeated applications of myo-necrotic bupivacaine. Acta Neuropathol (Berl) 1995;89:380-384.
60. Wong SH, Lowes KN, Quigley AF et al. DNA electroporation in vivo targets mature fibres in dystrophic mdx muscle. Neuromuscul Disord 2005;15:630-641.
61. Jankowski RJ, Deasy BM, Cao B et al. The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells. J Cell Sci 2002;115:4361-4374.
62. Jankowski RJ, Huard J. Establishing reliable criteria for isolating myogenic cell fractions with stem cell properties and enhanced regenerative capacity. Blood Cells Mol Dis 2004;32:24-33.
63. Jankowski RJ, Huard J. Myogenic cellular transplantation and regeneration: Sorting through progenitor heterogeneity. Panminerva Med 2004;46:81-91.
64. Praud C, Montarras D, Pinset C et al. Dose effect relationship between the number of normal progenitor muscle cells grafted in mdx mouse skeletal striated muscle and the number of dystrophin-positive fibres. Neurosci Lett 2003;352:70-72.
65. Hoffman EP, Morgan JE, Watkins SC et al. Somatic reversion/suppression of the mouse mdx phenotype in vivo. J Neurol Sci 1990;99:9-25.
66. Klein CJ, Coovert DD, Bulman DE et al. Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): Evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet 1992;50:950-959.
67. Thanh LT, Nguyen TM, Helliwell TR et al. Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin. Am J Hum Genet 1995;56:725-731.
68. Herzog EL, Chai L, Krause DS. Plasticity of marrow-derived stem cells. Blood 2003;102:3483-3493.
69. Wagers AJ, Sherwood RI, Christensen JL et al. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002;297:2256-2259.
70. Ferrari G, Stornaiuolo A, Mavilio F. Failure to correct murine muscular dystrophy. Nature 2001;411:1014-1015.
71. Shi D, Reinecke H, Murry CE et al. Myogenic fusion of human bone marrow stromal cells, but not hematopoietic cells. Blood 2004;104:290-294.
72. Lapidos KA, Chen YE, Earley JU et al. Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle. J Clin Invest 2004;114:1577-1585.
73. Kapsa RM, Quigley AF, Vadolas J et al. Targeted gene correction in the mdx mouse using short DNA fragments: Towards application with bone marrow-derived cells for autologous remodeling of dystrophic muscle. Gene Ther 2002;9:695-699.
74. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49.
75. Reyes M, Lund T, Lenvik T et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001;98:2615-2625.
76. Schwartz RE, Reyes M, Koodie L et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002;109:1291-1302.
77. Gojo S, Gojo N, Takeda Y et al. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res 2003;288:51-59.
78. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-74.
79. Pochampally RR, Neville BT, Schwarz EJ et al. Rat adult stem cells (marrow stromal cells) engraft and differentiate in chick embryos without evidence of cell fusion. Proc Natl Acad Sci U S A 2004;101:9282-9285.
80. De Bari C, Dell'Accio F, Vandenabeele F et al. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol 2003;160:909-918.
81. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995;18:1417-1426.
82. Natsu K, Ochi M, Mochizuki Y et al. Allogeneic bone marrow-derived mesenchymal stromal cells promote the regeneration of injured skeletal muscle without differentiation into myofibers. Tissue Eng 2004;10:1093-1112.
83. Peister A, Mellad JA, Larson BL et al. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004;103:1662-1668.
84. Tamura H, Okamoto S, Iwatsuki K et al. In vivo differentiation of stem cells in the aorta-gonad-mesonephros region of mouse embryo and adult bone marrow. Exp Hematol 2002;30:957-966.
85. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
86. Martin DR, Cox NR, Hathcock TL et al. Isolation and characterization of multipotential mesenchymal stem cells from feline bone marrow. Exp Hematol 2002;30:879-886.
87. Kondo M, Wagers AJ, Manz MG et al. Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu Rev Immunol 2003;21:759-806.
88. Uchida N, Weissman IL. Searching for hematopoietic stem cells: Evidence that Thy-1.1lo Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow. J Exp Med 1992;175:175-184.
89. Bonnet D. Haematopoietic stem cells. J Pathol 2002;197:430-440.
90. Dzierzak E. Hematopoietic stem cells and their precursors: Developmental diversity and lineage relationships. Immunol Rev 2002;187:126-138.
91. Lee JY, Qu-Petersen Z, Cao B et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 2000;150:1085-1100.
92. Ikezawa M, Cao B, Qu Z et al. Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation. Hum Gene Ther 2003;14:1535-1546.
93. Sherwood RI, Christensen JL, Conboy IM et al. Isolation of adult mouse myogenic progenitors: Functional heterogeneity of cells within and engrafting skeletal muscle. Cell 2004;119:543-554.
94. Mitchell PO, Mills T, O'Connor RS et al. Sca-1 negatively regulates proliferation and differentiation of muscle cells. Dev Biol 2005;283:240-252.
95. Shen X, Collier JM, Hlaing M et al. Genome-wide examination of myoblast cell cycle withdrawal during differentiation. Dev Dyn 2003;226:128-138.
96. Epting CL, Lopez JE, Shen X et al. Stem cell antigen-1 is necessary for cell-cycle withdrawal and myoblast differentiation in C2C12 cells. J Cell Sci 2004;117:6185-6195.
97. Ma X, de Bruijn M, Robin C et al. Expression of the Ly-6A (Sca-1) lacZ transgene in mouse haematopoietic stem cells and embryos. Br J Haematol 2002;116:401-408.
98. Luna G, Paez J, Cardier JE. Expression of the hematopoietic stem cell antigen Sca-1 (LY-6A/E) in liver sinusoidal endothelial cells: Possible function of Sca-1 in endothelial cells. Stem Cells Dev 2004;13:528-535.
99. Baddoo M, Hill K, Wilkinson R et al. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 2003;89:1235-1249.
100. Oh H, Bradfute SB, Gallardo TD et al. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 2003;100:12313-12318.
101. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science 1988;241:58-62.
102. Welm BE, Tepera SB, Venezia T et al. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol 2002;245:42-56.
103. Triel C, Vestergaard ME, Bolund L et al. Side population cells in human and mouse epidermis lack stem cell characteristics. Exp Cell Res 2004;295:79-90.
104. Svetlov SI, Ignatova TN, Wang KK et al. Lysophosphatidic acid induces clonal generation of mouse neurospheres via proliferation of Sca-1- and AC133-positive neural progenitors. Stem Cells Dev 2004;13:685-693.
105. Baumann U, Crosby HA, Ramani P et al. Expression of the stem cell factor receptor c-kit in normal and diseased pediatric liver: Identification of a human hepatic progenitor cell? Hepatology 1999;30:112-117.
106. Besmer P, Manova K, Duttlinger R et al. The kit-ligand (steel factor) and its receptor c-kit/W: Pleiotropic roles in gametogenesis and melanogenesis. Dev Suppl 1993;125-137.
107. Broudy VC, Lin NL, Priestley GV et al. Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen. Blood 1996;88:75-81.
108. Erlandsson A, Larsson J, Forsberg-Nilsson K. Stem cell factor is a chemoattractant and a survival factor for CNS stem cells. Exp Cell Res 2004;301:201-210.
109. Fujio K, Evarts RP, Hu Z et al. Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat. Lab Invest 1994;70:511-516.
110. Glaspy J. Clinical applications of stem cell factor. Curr Opin Hematol 1996;3:223-229.
111. Matsui Y, Zsebo KM, Hogan BL. Embryonic expression of a haematopoietic growth factor encoded by the Sl locus and the ligand for c-kit. Nature 1990;347:667-669.
112. Meininger CJ, Yano H, Rottapel R et al. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 1992;79:958-963.
113. Okumura N, Tsuji K, Ebihara Y et al. Chemotactic and chemokinetic activities of stem cell factor on murine hematopoietic progenitor cells. Blood 1996;87:4100-4108.
114. Peters EM, Tobin DJ, Botchkareva N et al. Migration of melanoblasts into the developing murine hair follicle is accompanied by transient c-Kit expression. J Histochem Cytochem 2002;50:751-766.
115. Sun L, Lee J, Fine HA. Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J Clin Invest 2004;113:1364-1374.
116. Lian Z, Toki J, Yu C et al. Intrathymically injected hemopoietic stem cells can differentiate into all lineage cells in the thymus: Differences between c-kit+ cells and c-kit < low cells. STEM CELLS 1997;15:430-436.
117. Ortiz M, Wine JW, Lohrey N et al. Functional characterization of a novel hematopoietic stem cell and its place in the c-Kit maturation pathway in bone marrow cell development. Immunity 1999;10:173-182.
118. Camirand G, Caron NJ, Asselin I et al. Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice. Transplantation 2001;72:38-44.
119. Guérette B, Wood K, Roy R et al. Efficient myoblast transplantation in mice immunosuppressed with monoclonal antibodies and CTLA4 Ig. Transplant Proc 1997;29:1932-1934.
120. Qu Z, Balkir L, van Deutekom JC et al. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 1998;142:1257-1267.
121. Wakeford S, Watt DJ, Partridge TA. X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve 1991;14:42-50.
122. Wernig A, Zweyer M, Irintchev A. Function of skeletal muscle tissue formed after myoblast transplantation into irradiated mouse muscles. J Physiol 2000;522:333-345.
123. Morgan JE, Pagel CN, Sherratt T et al. Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice. J Neurol Sci 1993;115:191-200.
124. Skuk D, Goulet M, Roy B et al. Myoblast transplantation in whole muscle of nonhuman primates. J Neuropathol Exp Neurol 2000;59:197-206.
125. Torrente Y, D'Angelo MG, Del Bo R et al. Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx mice. Cell Transplant 1999;8:247-258.
126. Neumeyer AM, DiGregorio DM, Brown RH, Jr. Arterial delivery of myoblasts to skeletal muscle. Neurology 1992;42:2258-2262.
127. Vierck JL, Dodson MV. Interpretation of cell culture phenomena. Methods Cell Sci 2000;22:79-81.
128. Lambert JF, Liu M, Colvin GA et al. Marrow stem cells shift gene expression and engraftment phenotype with cell cycle transit. J Exp Med 2003;197:1563-1572.
129. Quesenberry P, Habibian H, Dooner M et al. Physical and physiological plasticity of hematopoietic stem cells. Blood Cells Mol Dis 2001;27:934-937.
130. Huard J, Roy R, Bouchard JP et al. Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant Proc 1992;24:3049-3051.
131. Morgan JE, Hoffman EP, Partridge TA. Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J Cell Biol 1990;111:2437-2449.